Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

Dmello, C., Zhao, J., Chen, L., Gould, A., Castro, B., Arrieta, V. A., Zhang, D. Y., Kim, K.-S., Kanojia, D., Zhang, P., Miska, J., Yeeravalli, R., Habashy, K., Saganty, R., Kang, S. J., Fares, J., Liu, C., Dunn, G., Bartom, E., … Sonabend, A. M. (2023). Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-36878-2
Authors:
Crismita Dmello
Junfei Zhao
Li Chen
Andrew Gould
Brandyn Castro
Victor A. Arrieta
Daniel Y. Zhang
Kwang-Soo Kim
Deepak Kanojia
Peng Zhang
Jason Miska
Ragini Yeeravalli
Karl Habashy
Ruth Saganty
Seong Jae Kang
Jawad Fares
Connor Liu
Gavin Dunn
Elizabeth Bartom
Matthew J. Schipma
Patrick D. Hsu
Mahmoud S. Alghamri
Maciej S. Lesniak
Amy B. Heimberger
Raul Rabadan
Catalina Lee-Chang
Adam M. Sonabend
Affiliated Authors:
Junfei Zhao
Raul Rabadan
Columbia Affiliation:
Subjects:
Glioma (MeSH)
Glioblastoma (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1038/s41467-023-36878-2
PMID:
36949040
DOI:
10.1038/s41467-023-36878-2
Journal:
Nature Communications
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record

Record Created: